Authors: Pilepich, MV Winter, K John, MJ Mesic, JB Sause, W Rubin, P Lawton, C Machtay, M Grignon, D

Citation: Mv. Pilepich et al., Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate, INT J RAD O, 50(5), 2001, pp. 1243-1252

Authors: Sause, W Kolesar, P Taylor, S Johnson, D Livingston, R Komaki, R Emami, B Curran, W Byhardt, R Dar, AR Turrisi, A

Citation: W. Sause et al., Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group, CHEST, 117(2), 2000, pp. 358-364

Authors: Yuen, AR Zou, GY Turrisi, AT Sause, W Komaki, R Wagner, H Aisner, SC Livingston, RB Blum, R Johnson, DH

Citation: Ar. Yuen et al., Similar outcome of elderly patients in intergroup trial 0096 - Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma, CANCER, 89(9), 2000, pp. 1953-1960

Authors: Whitney, CW Sause, W Bundy, BN Malfetano, JH Hannigan, EV Fowler, WC Clarke-Pearson, DL Liao, SY

Citation: Cw. Whitney et al., Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea asan adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study, J CL ONCOL, 17(5), 1999, pp. 1339-1348

Authors: Movsas, B Scott, C Sause, W Byhardt, R Komaki, R Cox, J Johnson, D Lawton, C Dar, AR Wasserman, T Roach, M Lee, JS Andras, E

Citation: B. Movsas et al., The benefit of treatment intensification is age and histology-dependent inpatients with locally advanced nonsmall cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies, INT J RAD O, 45(5), 1999, pp. 1143-1149